Journals / Adli Tıp Dergisi / 2007 / Cilt: 21 - Sayı: 3

The abuse of piperazine derivatives

Piperazin türevlerinin kötüye kullanımı

Pages
31–38
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Common features and toxicity of piperazine derivatives abused and legal regulations related with this subject are discussed in this paper.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Recently, it has been reported that some piperazine derivatives are abused which is common all-around the world, causing serious toxicity and even death in some cases.
📊
Key Findings & Data:With this purpose, the files related with piperazine derivatives sent to the 5th Specialty Board of The Council of Forensic Medicine in the last one year period have been evaluated regarding event place, captured piperazine derivative and other captured subtances.
💡
Conclusion & Impact:Common features and toxicity of piperazine derivatives abused and legal regulations related with this subject are discussed in this paper.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Recently, it has been reported that some piperazine derivatives are abused which is common all-around the world, causing serious toxicity and even death in some cases. Present study has been designed to investigate the abuse of these piperazine derivatives in our country. With this purpose, the files related with piperazine derivatives sent to the 5th Specialty Board of The Council of Forensic Medicine in the last one year period have been evaluated regarding event place, captured piperazine derivative and other captured subtances. Obtained data showed that abuse of these piperazine derivatives increased in our country, as well. Common features and toxicity of piperazine derivatives abused and legal regulations related with this subject are discussed in this paper.

Özet

Son yıllarda, piperazinden türetilen bazı maddelerin kötüye kullanıldığı, kötüye kullanımlarının tüm dünyada yaygınlaştığı, bazı olgularda bu maddelerle ilişkili ciddi toksisite ve hatta ölümler olduğu bildirilmektedir. Sunulan çalışma, bu piperazin türevlerinin ülkemizdeki kötüye kullanımını araştırmak üzere planlanmıştır. Bu amaçla, son bir yıllık dönemde Adli Tıp Kurumu 5. İhtisas Kurulu'na gönderilen piperazin türevleri ile ilgili dosyalar incelenerek, olay yeri, yakalanan piperazin türevi, varsa beraberinde yakalanan maddeler birlikte değerlendirilmiştir. Elde edilen veriler, bu piperazin türevlerinin kötüye kullanımının ülkemizde de yaygınlaştığını göstermektedir. Kötüye kullanılan piperazin türevlerinin genel özellikleri ve toksisiteleri ile bu konuda alınabilecek yasal önlemler makale içinde tartışılmaktadır.

🔖

Cite This Article

AŞICIOĞLU, F., BELCE, A., ÇELİK, P. Y. (2022). The abuse of piperazine derivatives. Adli Tıp Dergisi, Cilt: 21 - Sayı: 3, 31–38. https://ajindex.com/articles/428860

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. McGraw-Hill, 2006: 461-500. 2.Sweetman SC, editor. Martindale: The Complete Drug Reference. 33rd ed. The Pharmaceutical Press, 2002: 271-314. 3.Olson KR, editor. Poisoning & Drug Overdose. 4th ed. McGraw-Hill, 2004: 96-98. 4.Sweetman SC, editor. Martindale: The Complete Drug Reference. 33rd ed. The Pharmaceutical Press, 2002: 547. 5.Sweetman SC, editor. Martindale: The Complete Drug Reference. 33rd ed. The Pharmaceutical Press, 2002: 649-714. 6.Sweetman SC, editor. Martindale: The Complete Drug Reference. 33rd ed. The Pharmaceutical Press, 2002: 987. 7.Sweetman SC, editor. Martindale: The Complete Drug Reference. 33rd ed. The Pharmaceutical Press, 2002: 1662. 8.Budevari S, editor. The Merck Index. 11th ed. Merck & Co., Inc, 1989:114. 9.Budevari S, editor. The Merck Index. 11th ed. Merck & Co., Inc, 1989: 639. 10.Cecchetti V, Schiaffella F, Tabarrini O, Fravolini A. (1,4-Benzothiazinyloxy)alkylpiperazine derivatives as potential antihypertensive agents. Bioorg Med Chem Lett, 2000; 10(5): 465-8. 11.Austin H, Monasterio E. Acute psychosis following ingestion of 'Rapture'. Australas Psychiatry, 2004; 12(4):406-8. 12.de Boe, D, Bosman IJ, Hidvegi E, et al. Piperazine-like compaunds: a new group of designer drugs-of-abuse on the European market. Forensic Sci Int, 2001; 121(1-2):47-56. 13.Gee P, Richardson S, Woltersdorf W, Moore G. Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christehurch, New Zealand. N Z Med J, 2005; 118(1227):U1784. 14.Balmelli C, Kupferschmidt H, Rentsch K, Schneemann Ml. [Fatal brain edema after ingestion of ecstasy and benzylpiperazine]. Dtsch Med Wochenschr, 2001; 126(28-29):809-11. 15.Wood DM, Dargan PI, Button J, Holt DW, Ovaska H, Ramsey J, Jones AL. Collapse, reported seizure and an unexpected pill. Lancet, 2007; 369(9571): 1490. 16.Budevari S, editor. The Merck Index. 11th ed. Merck & Co., Inc, 1989:1185. 17.Staack RF, Maurer HH. Metabolism of designer drugs of abuse. Curr Drug Metab, 2005; 6(3):259-74. 18.Cioli V, Corradino C, Piccinelli D, Rocchi MG, Valeri P. A comparative pharmacological study of trazodone, etoperidone and 1 - (m-chlorophenyl)piperazine. Pharmacol Res Commun, 1984; 16(1):85- 100. 19.Benfenati E, Caccia S, Delia Vedova F. 1 -(o-Methoxyphenyl)piperazine is a metabolite of drugs bearing a methoxyphenylpiperazine side-chain. J Pharm Pharmacol, 1987; 39(4):312-3. 20.Staac